Science Explorer Interactive view Map
Company · Edmonton · Canada

NAEJA-RGM Pharmaceuticals (Canada)

naeja-rgm.comROR OpenAlex
Research works
54
▼ 5% vs 2013–17
Citations
1.6k
30.1 per fractional work
Top-10% rate
8.5%
record average 16.5%
Open access
30%
world 28%

Not ranked overall: NAEJA-RGM Pharmaceuticals (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 5.45× its world share, 1 worksBiochemistry, Geneti…Pharmacology, Toxicology and Pharmaceutics: 8.08× its world share, 0 worksPharmacology, Toxico…Chemistry: 2.72× its world share, 0 worksChemistryEngineering: 0.28× its world share, 0 worksEngineeringMedicine: 2.77× its world share, 2 worksMedicineNursing: 5.82× its world share, 0 worksNursingPsychology: 1.12× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 8.1×. Every wedge is a field page.

Which keywords describe research at NAEJA-RGM Pharmaceuticals (Canada)?

By fractional works in all years, weighted toward what it does more of than the world: Synthesis, Anticancer, Medicinal Chemistry, Anticancer Agents, Biological Evaluation, Antimicrobial, Drug Discovery and Heterocyclic Compounds.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Synthesis10▲ 32×12 topics
  2. Anticancer6▲ 52×5 topics
  3. Anticancer Agents5▲ 39×6 topics
  4. Biological Evaluation5▲ 80×5 topics
  5. Medicinal Chemistry5▲ 27×7 topics
  6. Antimicrobial5▲ 34×4 topics
  7. Drug Discovery4▲ 18×9 topics
  8. Heterocyclic Compounds3▲ 38×2 topics
  9. Alkaloids3▲ 82×4 topics
  10. Antimicrobial Activity3▲ 30×2 topics
  11. Anti-inflammatory3▲ 19×4 topics
  12. Inflammation3▲ 2.3×13 topics
  13. Catalyst3▲ 45×2 topics
  14. Cell Signaling3▲ 14×4 topics
  15. Inhibitors3▲ 66×3 topics
  16. Angiogenesis2▲ 11×4 topics
  17. Mass Spectrometry2▲ 20×2 topics
  18. Cancer Therapy2▲ 6.3×6 topics
  19. Apoptosis2▲ 9.9×6 topics
  20. Derivatives2▲ 65×1 topic
  21. Heterocycles2▲ 21×4 topics
  22. Indirubin2▲ 282×1 topic
  23. Quinazoline2▲ 282×1 topic
  24. Quinoxaline2▲ 86×1 topic
  25. Biological Activities2▲ 19×2 topics
  26. PET Imaging2▲ 16×3 topics
  27. Tumor Microenvironment2▲ 9.9×2 topics
  28. DNA2▲ 104×1 topic
  29. Pharmacology2▲ 10.0×5 topics
  30. Topoisomerases2▲ 104×1 topic
  31. Antioxidant Activity2▲ 5.7×2 topics
  32. Cancer Progression2▲ 14×5 topics
  33. Antibiotic Resistance2▲ 7.2×3 topics
  34. Non-antibiotic Drugs2▲ 169×1 topic
  35. Phenothiazines2▲ 169×1 topic
  36. Cancer Treatment2▲ 11×3 topics
  37. Chiral Separation2▲ 23×1 topic
  38. Liquid Chromatography2▲ 19×1 topic
  39. Neurobiology2▲ 8.3×2 topics
  40. Microwave-Assisted Synthesis1▲ 33×2 topics

Which research topics does NAEJA-RGM Pharmaceuticals (Canada) publish most on?

By volume in 2022–2025: Bone health and treatments, Cannabis and Cannabinoid Research, Pharmacological Effects and Toxicity Studies and Cancer, Hypoxia, and Metabolism.

Bone health and treatments0Bone health and treatments: 0 fractional worksCannabis and Cannabinoid…0Cannabis and Cannabinoid Research: 0 fractional worksPharmacological Effects and Toxicity Studies: 0 fractional worksCancer, Hypoxia, and Metabolism: 0 fractional worksFibroblast Growth Factor…0Fibroblast Growth Factor Research: 0 fractional worksCancer, Lipids, and Metabolism: 0 fractional worksHemoglobinopathies and Related Disorders: 0 fractional worksAdvanced Battery Technol…0Advanced Battery Technologies Research: 0 fractional worksMedication Adherence and Compliance: 0 fractional worksBlood Pressure and Hypertension Studies: 0 fractional works
OncologyPharmacologyPediatrics, Perinatology and Child HealthCancer Research5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Bone health and treatments Oncology 0 works
  2. 2 Cannabis and Cannabinoid Research Pharmacology 0 works
  3. 3 Pharmacological Effects and Toxicity Studies Pediatrics, Perinatology and Child Health 0 works
  4. 4 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
  5. 5 Fibroblast Growth Factor Research Molecular Biology 0 works
  6. 6 Cancer, Lipids, and Metabolism Cancer Research 0 works
  7. 7 Hemoglobinopathies and Related Disorders Genetics 0 works
  8. 8 Advanced Battery Technologies Research Automotive Engineering 0 works
  9. 9 Medication Adherence and Compliance Family Practice 0 works
  10. 10 Blood Pressure and Hypertension Studies Cardiology and Cardiovascular Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available29.7%not open70.3%

World: 28% of research is openly available.

with international co-authors39.1%domestic only60.9%

World: 19% is written across borders.

How has NAEJA-RGM Pharmaceuticals (Canada)'s research output changed?

Output in 2018–2022 was 5% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Edmonton

All research institutions in Edmonton

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.